148 related articles for article (PubMed ID: 2911875)
21. Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506.
Murase N; Demetris AJ; Woo J; Tanabe M; Furuya T; Todo S; Starzl TE
Transplantation; 1993 Jan; 55(1):1-7. PubMed ID: 7678353
[TBL] [Abstract][Full Text] [Related]
22. PGG-glucan, a leukocyte-specific immunostimulant, does not potentiate GVHD or allograft rejection.
Washburn WK; Otsu I; Gottschalk R; Monaco AP
J Surg Res; 1996 May; 62(2):179-83. PubMed ID: 8632636
[TBL] [Abstract][Full Text] [Related]
23. The role of natural killer cell mediated caspases activation in a graft-versus-host disease model of semiallogeneic small bowel transplantation.
Fändrich F; Zepernick-Kalinski C; Gebhardt H; Henne-Bruns D; Zavazava N; Lin X
Transpl Immunol; 1999 Mar; 7(1):1-7. PubMed ID: 10375071
[TBL] [Abstract][Full Text] [Related]
24. Prevention of graft-versus-host disease and the induction of transplant tolerance by low-dose UV-B irradiation of BM cells combined with cyclosporine immunosuppression.
Ohajekwe OA; Hardy MA; Oluwole SF
Transplantation; 1995 Dec; 60(12):1510-6. PubMed ID: 8545883
[TBL] [Abstract][Full Text] [Related]
25. Induction of chronic graft-versus-host disease in a rat model after transplantation of sensitized small bowel allografts.
Langrehr JM; Markus PM; Banner B; Lee KK; Schraut WH
Am J Surg; 1994 Jun; 167(6):579-85. PubMed ID: 8209932
[TBL] [Abstract][Full Text] [Related]
26. Graft-versus-host disease induced by small bowel allografts. Clinical course and pathology.
Schraut WH; Lee KK; Dawson PJ; Hurst RD
Transplantation; 1986 Mar; 41(3):286-90. PubMed ID: 3952800
[TBL] [Abstract][Full Text] [Related]
27. Small bowel transplantation in the rat: impact of various immunosuppressive regimens on graft-versus-host reaction.
Oberhuber G; Schmid T; Erdkönig R; Thaler W; Ofner D; Köröszi G; Klima G; Margreiter R
Eur Surg Res; 1991; 23(3-4):206-13. PubMed ID: 1782966
[TBL] [Abstract][Full Text] [Related]
28. Correlation between graft-versus-host induced immunosuppression and host natural killer cell activity in small bowel transplantation.
Fändrich F; Schröder J; Exner B; Papachrysanthou A; Peters J; Chambers W; Zavazava N
World J Surg; 1996 Oct; 20(8):1041-51. PubMed ID: 8798363
[TBL] [Abstract][Full Text] [Related]
29. Bacterial translocation during graft-versus-host disease after small bowel transplantation is reduced following inhibition of inducible nitric oxide synthesis.
Langrehr JM; Machens C; Zill E; Leder K; Nüssler A; Hoffman R; Neuhaus P
Transplantation; 2000 Jun; 69(11):2415-21. PubMed ID: 10868651
[TBL] [Abstract][Full Text] [Related]
30. NK activity during graft-versus-host disease and graft rejection in rats following intestinal semiallogenic and allogenic transplantation with or without mesenteric lymphadenectomy.
Frezza EE; Gerunda GE; Fassina A; DeFranchis R; Biffi R; Gurakar A; Fagiuoli S; Faccioli AM; Van Thiel DH
Transplantation; 1994 Sep; 58(6):698-701. PubMed ID: 7940689
[TBL] [Abstract][Full Text] [Related]
31. Graft-versus-host reaction in small-bowel transplantation and possibilities for its circumvention.
Watanabe K; Yagi T; Iwagaki H; Kimura Y; Mitsuoka N; Inagaki M; Tanaka S; Tanaka N
J Int Med Res; 2001; 29(3):222-8. PubMed ID: 11471860
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and classification of the severity of graft versus host disease after experimental small-bowel transplantation in small animal models.
Kizilisik TA; al-Sebayel M
Transplant Proc; 1997 Nov; 29(7):3030-3. PubMed ID: 9365656
[No Abstract] [Full Text] [Related]
33. Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin.
Stepkowski SM; Chen HF; Wang ME; Daloze P; Kahan BD
Transplantation; 1992 Feb; 53(2):258-64. PubMed ID: 1738917
[TBL] [Abstract][Full Text] [Related]
34. Amelioration of graft versus host disease with anti-ICAM-1 therapy.
Poritz LS; Page MJ; Tilberg AF; Koltun WA
J Surg Res; 1998 Dec; 80(2):280-6. PubMed ID: 9878325
[TBL] [Abstract][Full Text] [Related]
35. Graft versus host disease in small bowel transplantation.
Clark CL; Price BA; Malcolm P; Lear PA; Wood RF
Br J Surg; 1991 Sep; 78(9):1077-9. PubMed ID: 1933190
[TBL] [Abstract][Full Text] [Related]
36. Syngeneic small-bowel grafting increases susceptibility to lethal graft-versus-host disease in the rat.
Kobayashi E; Kamada N; Enosawa S; Toyama N; Miyata M
Eur Surg Res; 1995; 27(1):19-26. PubMed ID: 7890001
[TBL] [Abstract][Full Text] [Related]
37. Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation.
Miyauchi T; Ishikawa M; Tashiro S; Hisaeda H; Nagasawa H; Himeno K
Transplantation; 1998 Jan; 65(1):27-32. PubMed ID: 9448139
[TBL] [Abstract][Full Text] [Related]
38. Portal versus systemic venous drainage for small-bowel allografts.
Schraut WH; Abraham VS; Lee KK
Surgery; 1985 Sep; 98(3):579-86. PubMed ID: 3875908
[TBL] [Abstract][Full Text] [Related]
39. Prevention of graft-versus-host disease by intrathymic injection of recipient-type splenocytes into donor.
Vaidya S; Wang CC; Roorda C; Billings A; Rajaraman S; Fish JC
Transplantation; 1996 Nov; 62(9):1366-8. PubMed ID: 8932289
[TBL] [Abstract][Full Text] [Related]
40. Immunosuppression by succinylacetone. II. Prevention of graft-vs-host disease.
Hess RA; Tschudy DP; Blaese RM
J Immunol; 1987 Nov; 139(9):2845-9. PubMed ID: 2889780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
